Wyndly

Wyndly is a telehealth company revolutionizing allergy care through virtual consultations. We help patients manage and treat allergies using FDA-approved sublingual immunotherapy, making care accessible, affordable, and convenient. Founded by healthcare experts from top universities, Wyndly is backed by Y Combinator and leading healthcare investors. Our physician-led platform connects patients with board-certified doctors for personalized treatment plans, reducing administrative burdens while maintaining high-quality care standards. Wyndly exclusively focuses on allergy care, using specialized protocols for SLIT drops and tablets, creating a streamlined experience for both patients and providers. We prioritize patient outcomes by combining cutting-edge technology with clinical expertise, ensuring treatments are evidence-based and continuously monitored for effectiveness.